JP2007216051A - 人間の視力のトレーニング装置 - Google Patents
人間の視力のトレーニング装置 Download PDFInfo
- Publication number
- JP2007216051A JP2007216051A JP2007120850A JP2007120850A JP2007216051A JP 2007216051 A JP2007216051 A JP 2007216051A JP 2007120850 A JP2007120850 A JP 2007120850A JP 2007120850 A JP2007120850 A JP 2007120850A JP 2007216051 A JP2007216051 A JP 2007216051A
- Authority
- JP
- Japan
- Prior art keywords
- visual
- training
- people
- zone
- person
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012549 training Methods 0.000 title claims abstract description 113
- 230000004438 eyesight Effects 0.000 title claims abstract description 48
- 230000000007 visual effect Effects 0.000 claims abstract description 151
- 238000012545 processing Methods 0.000 claims abstract description 8
- 230000004044 response Effects 0.000 claims description 10
- 230000000638 stimulation Effects 0.000 abstract description 19
- 230000003287 optical effect Effects 0.000 abstract description 14
- 230000007704 transition Effects 0.000 description 56
- 238000000034 method Methods 0.000 description 40
- 230000004382 visual function Effects 0.000 description 35
- 230000036961 partial effect Effects 0.000 description 31
- 230000006378 damage Effects 0.000 description 30
- 238000011084 recovery Methods 0.000 description 25
- 210000001328 optic nerve Anatomy 0.000 description 18
- 230000015556 catabolic process Effects 0.000 description 12
- 238000006731 degradation reaction Methods 0.000 description 12
- 230000004304 visual acuity Effects 0.000 description 12
- 210000002569 neuron Anatomy 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 208000014674 injury Diseases 0.000 description 9
- 230000004393 visual impairment Effects 0.000 description 9
- 201000004569 Blindness Diseases 0.000 description 8
- 230000006735 deficit Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229940068196 placebo Drugs 0.000 description 8
- 239000000902 placebo Substances 0.000 description 8
- 238000012552 review Methods 0.000 description 8
- 208000029257 vision disease Diseases 0.000 description 8
- 241000282412 Homo Species 0.000 description 7
- 206010047555 Visual field defect Diseases 0.000 description 6
- 206010047571 Visual impairment Diseases 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 230000007547 defect Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 208000028389 Nerve injury Diseases 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000001771 impaired effect Effects 0.000 description 5
- 230000008764 nerve damage Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 208000029028 brain injury Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000005043 peripheral vision Effects 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 238000002645 vision therapy Methods 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006931 brain damage Effects 0.000 description 3
- 231100000874 brain damage Toxicity 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 238000007492 two-way ANOVA Methods 0.000 description 3
- 210000000857 visual cortex Anatomy 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 2
- 206010039729 Scotoma Diseases 0.000 description 2
- 208000004350 Strabismus Diseases 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001668 ameliorated effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000008403 visual deficit Effects 0.000 description 2
- 206010048909 Boredom Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000001738 Nervous System Trauma Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000009509 cortical damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000035497 disorder of visual system Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010150 least significant difference test Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 208000028412 nervous system injury Diseases 0.000 description 1
- 230000008279 neurobiological mechanism Effects 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 210000000977 primary visual cortex Anatomy 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003994 retinal ganglion cell Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001927 transneuronal effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000004412 visual outcomes Effects 0.000 description 1
Images
Landscapes
- Rehabilitation Tools (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007120850A JP2007216051A (ja) | 2007-05-01 | 2007-05-01 | 人間の視力のトレーニング装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007120850A JP2007216051A (ja) | 2007-05-01 | 2007-05-01 | 人間の視力のトレーニング装置 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000567166A Division JP2002523183A (ja) | 1998-08-27 | 1998-08-27 | 人間の視力のトレーニング方法および装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007216051A true JP2007216051A (ja) | 2007-08-30 |
| JP2007216051A5 JP2007216051A5 (enExample) | 2008-11-20 |
Family
ID=38493872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007120850A Pending JP2007216051A (ja) | 2007-05-01 | 2007-05-01 | 人間の視力のトレーニング装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007216051A (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7513622B2 (en) | 2006-10-04 | 2009-04-07 | Isport, Llc | System and method of enhancing a retino-geniculo-cortical pathway for a particular physical activity |
| JP2024068178A (ja) * | 2022-11-03 | 2024-05-17 | エスアルファセラピューティクス，インコーポレーテッド | 視力を改善するためのデジタル装置およびアプリケーション |
| JP2024078290A (ja) * | 2022-11-29 | 2024-06-10 | 正彦 仲井 | 視覚検査並びに改善訓練システム及びその活用方法 |
-
2007
- 2007-05-01 JP JP2007120850A patent/JP2007216051A/ja active Pending
Non-Patent Citations (1)
| Title |
|---|
| JPN5001018324, Ｅ．ＫＡＳＴＥＮ， Ｂ．Ａ．ＳＡＢＥＬ, ""Ｖｉｓｕａｌ ｆｉｅｌｄ ｅｎｌａｒｇｅｍｅｎｔ ａｆｔｅｒ ｃｏｍｐｕｔｅｒ ｔｒａｉｎｉｎｇ ｉｎ ｂｒａｉｎ−ｄａｍａｇｅｄ ｐａｔｉｅｎｔｓ ｗｉｔｈ ｈｏｍｏｎｙｍｏｕｓ ｄｅｆｉｃｉｔｓ", ＲＥＳＴＯＲ． ＮＥＵＲＯＬ． ＮＥＵＲＯＳＣＩ．, 19950801, 第８巻，第３号, ｐ．１１３−１２７ * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7513622B2 (en) | 2006-10-04 | 2009-04-07 | Isport, Llc | System and method of enhancing a retino-geniculo-cortical pathway for a particular physical activity |
| US7621639B2 (en) | 2006-10-04 | 2009-11-24 | Syed Khizer Rahim Khaderi | Method of developing a visual processing profile based on a retino-geniculo-cortical pathway |
| US7938539B2 (en) | 2006-10-04 | 2011-05-10 | Syed Khizer Rahim Khaderi | Method of developing a visual processing profile based on a retino-geniculo-cortical pathway |
| JP2024068178A (ja) * | 2022-11-03 | 2024-05-17 | エスアルファセラピューティクス，インコーポレーテッド | 視力を改善するためのデジタル装置およびアプリケーション |
| JP7696407B2 (ja) | 2022-11-03 | 2025-06-20 | エスアルファセラピューティクス，インコーポレーテッド | 視力を改善するためのデジタル装置およびアプリケーション |
| JP2024078290A (ja) * | 2022-11-29 | 2024-06-10 | 正彦 仲井 | 視覚検査並びに改善訓練システム及びその活用方法 |
| JP7650079B2 (ja) | 2022-11-29 | 2025-03-24 | 正彦 仲井 | 視覚検査並びに改善訓練システム及びその活用方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1107721B1 (en) | Device for the training of human vision | |
| Kasten et al. | Visual field enlargement after computer training in brain-damaged patients with homonymous deficits: an open pilot trial | |
| Mueller et al. | Recovery of visual field defects: a large clinical observational study using vision restoration therapy | |
| US7367671B2 (en) | Process and device for the training of human vision | |
| Kasten et al. | Computer-based training for the treatment of partial blindness | |
| Sabel et al. | Non-invasive alternating current stimulation improves vision in optic neuropathy | |
| Kasten et al. | Visual field recovery after vision restoration therapy (VRT) is independent of eye movements: an eye tracker study | |
| Dundon et al. | Visual rehabilitation: visual scanning, multisensory stimulation and vision restoration trainings | |
| Kasten et al. | Computer-based training of stimulus detection improves color and simple pattern recognition in the defective field of hemianopic subjects | |
| Kasten et al. | Restoration of vision II: residual functions and training-induced visual field enlargement in brain-damaged patients | |
| EP2922461B1 (en) | Clustered volley method and apparatus | |
| Kasten et al. | Stability of Visual Field Enlargements Following Computer-Based Restitution Training Results of a Follow-up | |
| US7682021B2 (en) | System and methods for the treatment of retinal diseases | |
| EP3177200A1 (en) | Methods and kits for diagnosing, assessing or quantitating drug use, drug abuse and narcosis, internuclear ophthalmoplegia, attention deficit hyperactivity disorder (adhd), chronic traumatic encephalopathy, schizophrenia spectrum disorders and alcohol consumption | |
| Ajina et al. | Rehabilitation of damage to the visual brain | |
| Werth | Cerebral blindness and plasticity of the visual system in children. A review of visual capacities in patients with occipital lesions, hemispherectomy or hydranencephaly | |
| Schmielau et al. | Recovery of visual fields in brain-lesioned patients by reaction perimetry treatment | |
| Werth et al. | Restitution of visual functions in cerebrally blind children | |
| US20150105689A1 (en) | Pattern electroretinography for evaluating a neurological condition | |
| JP2007216051A (ja) | 人間の視力のトレーニング装置 | |
| Yadav et al. | Optimization of the pattern visual evoked potential (VEP) in the visually-normal and mild traumatic brain injury (mTBI) populations | |
| Gross et al. | Visually guided behavior after V1 lesions in young and adult monkeys and its relation to blindsight in humans | |
| Heilman et al. | Neglect I: clinical and anatomic issues | |
| Eason | Selective attention effects on retinal and forebrain responses in humans: A replication and extension | |
| Pandey et al. | Rapid recovery from cortical visual impairment in a pediatric patient following vision training: A case study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081002 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100408 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100916 |